Tara Man Kadayat, PhD, MS, BPharm, GCCTL

Has grant

Assistant Professor

Larkin University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Tara Man Kadayat is an Assistant Professor at Larkin University in the United States. Her research focuses on the therapeutic potential of various chemical compounds in treating inflammatory disorders, Alzheimer's disease, and cancer. Recent publications include studies on antitrypanosomal agents and the synthesis of bioavailable compounds with diverse biological activity. Dr. Kadayat's work contributes significantly to the fields of medicinal chemistry and pharmacology.

Recent Grants

Grant: Close

Korea Research Fellowship (Brain Pool Program)

Open Date: 2020-06-01

Close Date: 2021-05-01

Grant: Close

Design and Discovery of NSD Inhibitors

Open Date: 2018-06-01

Close Date: 2021-05-01

Grant: Close

■ Development of a therapeutic drug for metabolic diseases targeting ERRγ

Open Date: 2018-02-01

Close Date: 2021-02-01

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (2)

R. Kiplin Guy

UNITED STATES

View details

Youngjoo Kwon

Professor

Ewha Womans University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tara Man Kadayat, PhD, MS, BPharm, GCCTL

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Antitrypanosomal Chloronitrobenzamides

Discovery of the therapeutic potential of PPARδ agonist bearing 1,3,4- thiadiazole in inflammatory disorders

Highly potent and selective PPARδ agonist reverses memory deficits in mouse models of Alzheimer's disease

Synthesis and biological evaluation of 4,7,9-trisubstituted benzoxazepines as antileishmanial agents

Optimization of Orally Bioavailable Antileishmanial 2,4,5-Trisubstituted Benzamides

Di-indenopyridines as topoisomerase II-selective anticancer agents: Design, synthesis, and structure–activity relationships

Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors

Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships

Potent inhibitory activity of hydroxylated 2-benzylidene-3,4-dihydronaphthalen-1(2H)-ones on LPS-stimulated reactive oxygen species production in RAW 264.7 macrophages

Antioxidative and anti-inflammatory activity of psiguadial B and its halogenated analogues as potential neuroprotective agents

Collaborators (2)

R. Kiplin Guy

Youngjoo Kwon

Make your next move.